-

GOOGL/GOOG Investors: Alphabet Inc. Shares Declined By $16.46 On July 16, 2026 –Contact Kirby McInerney LLP to Discuss Your Rights

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Alphabet Inc. (“Alphabet” or the “Company”) (NASDAQ: GOOGL; GOOG) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until December 1, 2026 to ask the Court to appoint them as lead plaintiff.

[CONTACT THE FIRM IF YOU SUFFERED A LOSS]

What Is The Lawsuit About?

The lawsuit has been filed on behalf of investors who purchased securities during the period of May 19, 2026 through July 16, 2026, inclusive (“the Class Period”). The lawsuit alleges that Alphabet failed to disclose that: (i) the Gemini 3.5 Pro was delivering disappointing training results; and (ii) as a result, the launch of Gemini 3.5 Pro would be significantly delayed.

On July 16, 2026, Bloomberg reported that Google is “months behind schedule on delivering Gemini 3.5 Pro, its most powerful flagship AI model,” due to the Company’s ongoing coding efforts. The report stated, “[l]ate last month, Google updated the data being used to train Gemini in an attempt to improve [its] skills, but the results were disappointing.” On this news, the price of Alphabet shares declined by $16.46 per share, or approximately 4.4%, from $370.92 per share on July 15, 2026 to close at $354.46 on July 16, 2026.

On September 30, 2026 Google announced that it would release Gemini 4 Argon, which had already been rolled out “to a set of trusted cyber defenders through [its] Fairwind Program,” and Reuters reported that “Google no longer plans to release Gemini 3.5 Pro.”

[CLICK HERE TO LEARN MORE ABOUT THE LAWSUIT]

What Are My Options?

Courts do not consider applications filed after the relevant deadline. The lead plaintiff oversees the litigation on behalf of the class and may influence key decisions, including litigation strategy and settlement. Courts regularly appoint individual investors as lead plaintiffs, not only institutions. Learn more about the lead plaintiff process and eligibility requirements here.

[WHAT IS A SECURITIES CLASS ACTION?]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP

NASDAQ:GOOGL

Release Versions
$Cashtags

Contacts

More News From Kirby McInerney LLP

PORTILLO’S INC. PTLO INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 21.5% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Portillo’s Inc. (“Portillo’s” or the “Company”) (NASDAQ: PTLO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On August 5, 2025, Portillo’s reported its second quarter 2025 financial results, reducing its fiscal...

ARRIVENT BIOPHARMA AVBP INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 47.3% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Arrivent BioPharma (“Arrivent” or the “Company”) (NASDAQ: AVBP) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On October 6, 2026, Arrivent disclosed that its Phase 3 FURVENT trial of firmonertinib, the Company’...

FERVO ENERGY COMPANY FRVO INVESTORS: Contact Kirby McInerney LLP About the Firm’s Securities Investigation Following 16.6% Share Drop

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP reminds investors of its investigation on behalf of Fervo Energy Company (“Fervo” or the “Company”) (NASDAQ: FRVO) investors concerning the Company’s and/or members of its senior management’s possible violation of the federal securities laws or other unlawful business practices.[LEARN MORE ABOUT THE FIRM’S INVESTIGATION]What Happened?On August 12, 2026, Fervo reported its second quarter 2026 financial results, predicting the Company’...
Back to Newsroom